Enalapril Maleate Tablet
Product Images NDC 51655-110

5 FDA label images from Northwind Health Company, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Enalapril Maleate (NDC 51655-110). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (37366051 Ccb9 4ce6 9060 0d4fa9e00a66 01)

Image (37366051 Ccb9 4ce6 9060 0d4fa9e00a66 01)
Chemical structure of enalapril maleate, depicting molecular components including a phenyl group, ethyl ester, amide linkage, and a carboxyl functional group, consistent with the active ingredient in the product.*
FDA Label Image

Image (37366051 Ccb9 4ce6 9060 0d4fa9e00a66 02)

Image (37366051 Ccb9 4ce6 9060 0d4fa9e00a66 02)
A data table comparing incidence rates of adverse events between Enalapril maleate (n=573) and placebo (n=339). Events are categorized by body system including Body As A Whole, Cardiovascular, Digestive, Nervous/Psychiatric, Respiratory, Skin, and Urogenital, with incidence percentages listed for each treatment group.*
FDA Label Image

Image (37366051 Ccb9 4ce6 9060 0d4fa9e00a66 03)

Image (37366051 Ccb9 4ce6 9060 0d4fa9e00a66 03)
A dosage adjustment table for Enalapril maleate tablets showing initial doses in mg/day based on renal status and creatinine clearance. It includes dosing recommendations for normal renal function, mild impairment, moderate to severe impairment, and dialysis patients with clarifying footnotes about warnings and dosage adjustments.*
FDA Label Image
FDA Label Image

Label (51655 110 26 Rev A 09 22 Nhc)

Label (51655 110 26   Rev A 09 22 Nhc)
Label for Enalapril Maleate Tablets USP 5 mg, containing 90 tablets. The product is for oral use and labeled Rx only. The label includes storage instructions to keep at 20°-25°C, warnings to keep out of reach of children, and to store in the original container tightly closed. The labeler is Northwind Health Company, LLC. The NDC number shown is 51655-110-26.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.